Mattia Falchetto Osti

Papers

Total Citations

H-Index

About

Mattia Falchetto Osti is a leading figure in radiation oncology, whose research has fundamentally shaped the management of intracranial tumors, particularly through stereotactic radiosurgery (SRS). His primary focus lies in optimizing target delineation and dose fractionation for pituitary adenomas, a key contribution that has refined clinical protocols for treating residual or recurrent disease. Osti’s seminal 2016 paper, cited 96 times, systematically evaluates the efficacy of both single-fraction and multi-fraction SRS delivered via Gamma Knife and CyberKnife systems, providing critical evidence for balancing tumor control with the preservation of surrounding healthy tissue. Beyond pituitary tumors, his work has advanced the understanding of radiosurgical dose constraints for other brain lesions, influencing international treatment guidelines. With a career marked by high-impact, clinically actionable research, Osti’s studies serve as essential references for radiation oncologists and neurosurgeons seeking to maximize therapeutic precision. His dedication to evidence-based practice continues to drive innovation in stereotactic techniques, making him a pivotal contributor to modern radiosurgery.